IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers

IQOS, the leading heated tobacco product globally, recently received ‘reduced exposure’ authorization from the US Food and Drug Administration. Independent research focusing on IQOS marketing and potential impact on consumers’ perceptions and behavior, and ultimately public health, is critical. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Carla J., Abroms, Lorien C., Levine, Hagai, Romm, Katelyn F., Khayat, Amal, Wysota, Christina N., Duan, Zongshuan, Bar-Zeev, Yael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508084/
https://www.ncbi.nlm.nih.gov/pubmed/34639851
http://dx.doi.org/10.3390/ijerph181910551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508084/
https://www.ncbi.nlm.nih.gov/pubmed/34639851
http://dx.doi.org/10.3390/ijerph181910551

Ejemplares similares